Individuals Coming Off Weight-Loss Jabs Regain Pounds Four Times Faster Compared to People Using Diet and Exercise
New research reveals that patients who stop using blockbuster slimming jabs like Mounjaro or Wegovy may regain reduced body mass far faster than those who halt traditional lifestyle regimens.
Published data in a leading medical journal shows that while obese people often shed about a fifth of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying these drugs should be cognizant of the danger of quick weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.
That rate of recovery suggests a return to pre-treatment weight within about 18 months.
Comparing Treatments
The study, which examined 37 of studies involving over 9,000 of patients, compared the results of GLP-1 agonists with older methods.
The team emphasize that individuals who shed pounds through dieting usually see a more gradual creep back—approximately 100 grams monthly—post-intervention.
Explaining the Rapid Regain
Experts believe the way of the drugs accounts for the heightened regain.
The injections imitate a natural hormone called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone levels far above than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making binge eating a significant risk."
An Ongoing Disease?
The NHS advise the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Professionals say that, given the likelihood of weight regain, the therapy is often ongoing.
This opinion is echoed by drug manufacturers, who note that the findings "underscore the persistent character of excess weight," similar to managing diseases like high blood pressure.
User Testimonies
People who have come off the medication explain a intense resurgence of appetite.
"It felt as if something that goes on and you become ravenous," said an individual.
This difficulty is exacerbated if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Significant Use
Figures indicate that millions of people in the UK have used weight-loss jabs in the past year, with desire remaining high.
- Adoption is greater among females compared to men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the medications through private prescriptions rather than the NHS.
Ultimately, experts stress that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent solution and long-term success likely depends on ongoing lifestyle support.